Treating BCG-Refractory Disease and Explaining NMIBC Treatment Options to Patients

6 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
The second part of this NMIBC roundtable discussion, featuring Gordon Brown, DO, Tim Richardson, MD, Bryan Mehlhaff, MD, Chris Pieczonka, MD, and Eugene Cone, MD, addresses the increasing availability of intravesical and systemic therapies, the importance of accurate risk stratification, and the role of education for both health care providers and patients. The panelists highlight the operational hurdles of managing NMIBC in diverse clinical settings, from geographic and compliance issues to the need for navigators and standardized pathways for patient care.

#bladdercancer #cancer #oncology #healthcare
Category
Oncology
Be the first to comment

Up Next